Multiply Labs signs $85m deal with Retro Bio to automate anti-ageing therapies
Longevity Technology - 15-May-2024Promises faster development and wider access of cell therapies for age-related diseases
Multiply Labs
Robotics and pharma R&D company
The Multiply Labs team combines deep expertise in robotics and pharma R&D. Together, we are building the robotics infrastructure that will enable personalized medicine.
Visit website: https://multiplylabs.com/
Details last updated 30-Apr-2020
Multiply Labs News
Why 3D supplement printing holds a bright future for longevity
Forbes - 28-Apr-2020Vast potential when tapped for pharmaceutical medicine use as well
